Clinical trial · Observational
Adolescent Loss: The Impact of Loss on Adolescent Oncology Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Teen loss is not uncommon. Depression, emptiness, disbelief, hopelessness, and guilt are typical responses. How teens with cancer cope with the loss of a loved one or a close friend has not been well-studied in the bereavement or oncology literature. This study will describe the impact of loss on teen patients who are on treatment or have recently completed treatment for malignancy. We will look at baseline personality traits and ask teens to identify losses in their life. We will ask questions about coping and meaning-making after loss. A parent will be invited to participate -to measure parental awareness of teen loss and determine if parental coping affects teen coping. The inventories have been validated by other researchers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adolescent Oncology Patients | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Number of participants who have experienced the death of a friend or relative by type of loss.
- timeFrame
- Once on Day 1
- description
- The prevalence of loss among the participants will be calculated. The type of losses will be described.
- measure
- Descriptive statistics of coping efficacy scores, psychological distress scores, meaning-making scores, and complicated bereavement scores.
- timeFrame
- Once on Day 1
- description
- All data for this objective will be mainly analyzed in a descriptive manner. The score for coping efficacy will be calculated from the General Coping Efficacy instrument. In addition, a subset of participants who identify losing a friend to cancer will be invited to complete a 30-45 minute semi-structured interview.
Secondary outcomes (1)
- measure
- Number of parents with knowledge of losses experienced by adolescent child.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 13 Years
- Maximum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Age 13-21 inclusive at time of study enrollment * English speaking * Research participant carries a diagnosis of a malignancy (or serious non-malignant disorder requiring HSCT) \>12 months. * Research participant carries a diagnosis of a malignancy (or serious non-malignant disorder requiring HSCT) for \>6 months and \<12 months but has evidence of refractory/progressive disease. * Patients who have completed cancer-directed therapy \>36 months ago are not eligible. (Note: Allogenic transplant recipients will be considered "off-therapy" 1 year after HSCT.) * No known history of significant cognitive deficits (i.e. with major impairments) that would preclude completion of study measures; not meant to exclude research participants with mild learning problems. * Research participant and 1 parent willing to participate and provide consent/assent according to institutional guidelines. Parent may decline to participate in parental inventories, but consent to adolescent participation. Exclusion Criteria: * Less than 13-years of age at completion of therapy. * Patients on hospice who are without scheduled follow-up at St. Jude Children's Research Hospital (SJCRH) * "Observation" patients. Patients that are being followed by imaging due to previous identification of an atypical lesion on radiographic imaging not identified to have a specific diagnosis.
References
Publications (0)
Data not yet available